undamentalytics Newsletter
Sign in

Exascale Labs Holdings Inc. (XLAB) stock

Add to watchlist

Add holding +

NASDAQ: XLAB Nasdaq Application Software

Exascale Labs Holdings Inc. is a US-listed company in the application software industry. Its financial year ends in June.

Stock price today

Loading chart…

Third-party market data · may be delayed

Fair value per share

Under review: every model's value for Exascale Labs Holdings Inc. is far from the share price, which usually points to a data problem (a merger, a share-count change, a one-off) rather than a bargain or a bubble.

Price vs value

Under review: limited reported history: available models are shown without a Buy/Hold/Sell rating. We'll show the comparison once resolved.

Exascale Labs Holdings Inc. valuation: adjust assumptions and compare models →

The Fundamentalytics view

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Exascale Labs Holdings Inc.'s latest figures clears our strength thresholds.

Things to watch

  • Volatile shares. Over the past year the shares showed annualised volatility of 150% and a beta of -0.1 against the S&P 500.

Price chart

  • 1 day-28.2%
  • 1 week-39.8%
  • 1 month+45.7%
  • This year-79.7%
  • 1 year-79.7%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Earnings

Last results
September 28, 2026

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Agreement
  2. Leadership
  3. Results
  4. Leadership
  5. Leadership

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Exascale Labs Holdings Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: limited reported history: available models are shown without a Buy/Hold/Sell rating.

Valuation multiples over time Market data may be delayed

At fiscal year end 2026
Share price$10.43
Market value$15645
+ Net debt (− = net cash)−$3m
Enterprise value−$3m
Multiples
Price / sales 0.0x
Price / earnings —
Price / free cash flow —
EV / EBITDA —

Market value uses the period's diluted share count; figures for each fiscal year use that year's results and the price at year end. "Now" uses today's price and the last twelve months.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: High.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

No analyst estimates are published for Exascale Labs Holdings Inc.: too few analysts cover it.

Positioning

Short interest
0.2%
of tradable shares
Days to cover
0.05
at average volume
Short interest, 1 month
−46%
to October 15, 2026
Held by institutions
69%
of shares
Held by insiders
53.1%
of shares

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Recent prices are available. Older price history and the statistics that need it are being loaded in the background.

Return and risk by year

Calendar year 2026 to date
Return
XLAB−80%
Industry peers (median)−14%
S&P 500+11%
Months that ended higher
XLAB46%
S&P 50046%
Largest fall from a high during the year
XLAB−92%
S&P 500−9%

Worst fall since August 20, 2025: 92% from June 1, 2026 to October 14, 2026. Getting back needed a 1109% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$0.91 – $10.99
From 52-week high
−81.4%
vs 50-day average
−31.6%
vs 200-day average
−74.5%
Volatility (1 year)
150%
Beta vs S&P 500
-0.09

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
0 up, 1 down
typical move ±14.8%
After a week
0 up, 1 down
typical move ±43.0%
After a month
1 up, 0 down
typical move ±26.7%
Results releasedNext dayS&P 500 next day5 days21 days
September 28, 2026 −14.8% −0.9% −43.0% +26.7%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2025 Jun 2025 2026 Jun 2026
Income
Revenue 7 15
Gross profit 1 2
EBITDA −3 −5
Operating income −3 −5
Net income −8 −12
Diluted EPS −$5106.44 −$8108.26
Growth (year on year)
Revenue — +111.3%
Margins
Gross margin 15.8% 16.3%
EBITDA margin −43.3% −32.3%
Operating margin −43.4% −32.4%
Net margin −109.2% −82.1%
Free-cash-flow margin −14.4% −18.6%
Cash flow
Cash from operations −1 −3
Capital spending 0 0
Free cash flow −1 −3
Stock-based pay 0 0
Free cash flow after stock pay −1 −3
Balance sheet
Cash 4 3
Total debt 0 0
Net debt (negative = net cash) −4 −3
Diluted shares — —

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Financial health

1 of 2 checks passed · June 30, 2026
What it owns · $7m
Short-term assets $7mLonger-term assets $0m
What it owes, and who funded it · $32m
Short-term liabilities $32mLonger-term liabilities $0mShareholders' equity $-25m
  • Short-term assets cover short-term liabilities $7m of assets due within a year against $32m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $7m short-term assets against $0 of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Exascale Labs Holdings Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Where the revenue comes from

Fiscal year to June 30, 2026
Products and services
Line of business Revenue Share YoY
Revenue From Intelligent Computing Power Service $14.7M 98.9% ▲ 124.0%
Revenue From Comprehensive Data Center Services $157,862 1.1% ▼ 66.4%
Geography
Region Revenue Share YoY
Hong Kong $4.5M 30.6% ▲ 656.7%
United States $3.9M 26.4% ▲ 87.7%
Canada $3.7M 24.8% ▲ 155.0%
Singapore $2M 13.6% ▼ 18.6%
United Kingdom $666,103 4.5% ▲ 70.0%

From Exascale Labs Holdings Inc.'s 10-K filed September 28, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Insider trading activity

Full insider history and chart
Insider purchases History → $0 0 trades by 0 insiders, last 12 months Insider sales History → $0 0 trades by 0 insiders
Net ▲ $0 net buying

No open-market insider trades reported in the last 12 months.

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

  • September 28, 2026

Recent SEC filings

Data status

When each part of this page on Exascale Labs Holdings Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Exascale Labs Holdings Inc. in brief

What does Exascale Labs Holdings Inc. do?
Exascale Labs Holdings Inc. is a US-listed company in the application software industry. Its financial year ends in June.
What is Exascale Labs Holdings Inc.'s stock ticker?
Exascale Labs Holdings Inc. trades under the ticker XLAB on Nasdaq. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Exascale Labs Holdings Inc.'s market cap?
On June 30, 2026, Exascale Labs Holdings Inc.'s market capitalisation was about $15,645 and net debt of -$2.7M. Market figures come from third-party market data and may be delayed.